GSK620
GSK620, a chemical probe, is a potent and orally active pan-BD2 inhibitor with excellent broad selectivity, developability and in vivo oral pharmacokinetics. GSK620 is highly selective for the BET-BD2 family of proteins, with >200-fold selectivity over all other bromodomains. GSK620 shows an anti-inflammatory phenotype in human whole blood[1].
Product Specifications
CAS Number
2088410-46-0
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/gsk620.html
Purity
99.79
Solubility
DMSO : 33.33 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C1=CC(C(NC2CC2)=O)=CN(CC3=CC=CC=C3)C1=O)NC
Molecular Formula
C18H19N3O3
Molecular Weight
325.36
Precautions
H302, H315, H319
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
P24-HIV (p24/661), CF405S conjugate, 0.1mg/mL
GAD1 / GAD67 (GABAergic Neuronal Marker) (GAD1/2563), 0.2mg/mL
![PE/Elab Fluor® 594 Mouse IgG1, κ Isotype Control[MOPC-21]](https://cdn.genprice.uk/products/763/68dd14a6061270361e7d1cf9/imageurl/e-ab-f09792p.webp)